Dr. Zemanick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13123 E 16th Ave
Aurora, CO 80045Phone+1 720-777-1234Fax+1 720-777-7284
Education & Training
U Colorado2004 - 2008
Children's National HospitalResidency, Pediatrics, 1999 - 2002
Albert Einstein College of MedicineClass of 1999
Certifications & Licensure
CO State Medical License 2004 - 2025
MD State Medical License 2002 - 2005
DC State Medical License 2001 - 2004- American Board of Pediatrics Pediatric Pulmonology
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF) Start of enrollment: 2011 Apr 01
- PK Study of N91115 in Cystic Fibrosis Patients Start of enrollment: 2014 Oct 01
- Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation Start of enrollment: 2015 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 159 citationsAirway microbiota across age and disease spectrum in cystic fibrosisEdith T. Zemanick, Brandie D. Wagner, Charles E. Robertson, Richard C. Ahrens, James F. Chmiel
The European Respiratory Journal. 2017-11-01 - 109 citationsAssessment of Airway Microbiota and Inflammation in Cystic Fibrosis Using Multiple Sampling MethodsEdith T. Zemanick, Brandie D. Wagner, Charles E. Robertson, Mark J. Stevens, Stanley J. Szefler
Annals of the American Thoracic Society. 2015-02-23 - 4 citationsInfluence of Acid Blockade on the Aerodigestive Tract Microbiome in Children With Cystic Fibrosis.Racha T. Khalaf, Glenn T. Furuta, Brandie D. Wagner, Charles E. Robertson, Rachel Andrews
Journal of Pediatric Gastroenterology and Nutrition. 2021-04-01
Journal Articles
- Changes in Microbiome Diversity Following Beta-Lactam Antibiotic Treatment Are Associated with Therapeutic Versus Subtherapeutic Antibiotic Exposure in Cystic FibrosisGeovanny F Perez, Anastassios C Koumbourlis, Andrea Hahn, Robert J Freishtat, Edith T Zemanick, Hollis Chaney, Nature
- Novel Application of Aptamer Proteomic Analysis in Cystic Fibrosis Bronchoalveolar Lavage FluidScott D Sagel, Robin R Deterding, Emily M DeBoer, Jonathan Popler, Edith T Zemanick, Frank J Accurso, PROTEOMICS – Clinical Applications
- Volatile Molecules from Bronchoalveolar Lavage Fluid Can ‘Rule-In’ Pseudomonas Aeruginosa and ‘Rule-Out’ Staphylococcus Aureus Infections in Cystic Fibrosis PatientsChristiaan A Rees, Edith T Zemanick, Nature
Press Mentions
- Researchers Explore Trikafta in Younger PatientsAugust 25th, 2021
Characterizing Mucociliary Clearance in Young Children with Cystic FibrosisMarch 22nd, 2021
Studying Trikafta for Better Cystic Fibrosis CareJanuary 31st, 2020- Join now to see all
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
